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Abstract 
Purpose: To synthesize and evaluate the bioactivity of some N-substituted-2-({5-[(1E,3E)-4-(1,3-
benzodioxol-5-yl)-1,3-butadienyl]-1,3,4-oxadiazol-2-yl}sulfanyl)propanamides (9a-o) of the alkaloid 
piperine (1) extracted from P. nigrum (black pepper).  
Methods: Extract 1 was subjected to basic hydrolysis to obtain piperic acid (2). The heterocyclic 1,3,4-
oxadiazole ring was synthesized from 2 through the formation of an ester and carbohydrazide. A series 
of electrophiles, 8a-o, were synthesized in the presence of 10 % Na2CO3. The final compounds, 9a-o, 
were synthesized by stirring 5-[(1E,3E)-4-(1,3-benzodioxol-5-yl)-1,3-butadienyl]-1,3,4-oxadiazol-2-thiol 
(5) and 8a-o in LiH/DMF. Spectral analysis was performed using infrared (FTIR), proton nuclear 
magnetic resonance (1H-NMR) and electron impact mass spectrometry (EI-MS) to determine the 
structures of 9a-o. Antimicrobial activity was evaluated as zone of inhibition by disc diffusion method. 
Hemolytic and thrombolytic activities were determined by measuring absorbance before and after 
incubation of blood cells with test compound. 
Results: Compound 9d strongly inhibited Bacillus subtilis and Escherichia coli with zone of inhibition 
values of 16 mm for each. The reference drug, rifampicin, showed zone of inhibition of 21 and 23 mm 
against B. subtilis and E. coli, respectively. Compound 9a strongly inhibited Aspergillus niger with a 
zone of inhibition of 18 mm compared to the reference drug, fluconazole, with a zone of inhibition of 19 
mm.   
Conclusion: The newly synthesized compounds are more active antimicrobial agents than piperine. 
Compounds 9a and 9d are the most active. 
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Herbal drugs have a broad spectrum of 
therapeutic effects. Piper nigrum L. belongs to 
the family Piperaceae and has multiple uses in 
the food industry, perfumery and medicines [1]. 
1,3,4-Oxadiazole derivatives also possess 
remarkable bioactivities [2-6]. The quantitative 
and qualitative effects of substitution on 1,3,4-
ozadiazole prompted us to synthesize various 
propanamide derivatives with minimal toxicity 
and improved bioactivity. A series of 
propanamides bearing 1,3,4-oxadiazole and 
piperine moieties were synthesized with the aim 
of introducing new bioactive compounds.  
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P. nigrum L. (black pepper) was collected from 
Lahore, Pakistan in June 2014.  Dr. Zaheerud 
Din, a taxonomist in the Department of Botany, 
Government College University, Lahore, 
Pakistan, authenticated the sample as P. nigrum 
L. The Herbarium of the Department of Botany, 
Government College University, Lahore, 





The chemical reagents and solvents employed 
were purchased from Sigma-Aldrich and Merck. 
TLC on pre-coated silica gel G-25-UV254 plates 
with ethyl acetate and n-hexane solvent system 
was performed for pre-confirmation. A Griffin and 
George apparatus was used to record melting 
points using an open capillary tube. I.R. spectra 
were recorded on a Jasco-320-A 
spectrophotometer by the KBr pellet method. The 
proton-NMR spectra were recorded on Bruker 
spectrometers operating at 300/400 MHz. The 
mass spectra (EIMS) were recorded on a JMS-
HX-110. 
 
Extraction of piperine alkaloid (1) 
 
P. nigrum (1000 g) was ground and placed in a 
Soxhlet apparatus [7]. Methanol (1500 mL) was 
added, and the mixture was refluxed for 3 h. 
After evaporating the excess solvent, excess 
distilled water (250 mL) was added and the pH 
was adjusted to 9 - 10 with 4 % aqueous KOH. 
Piperine was precipitated and collected by 
filtration [8]. 
 
Synthesis of piperic acid (2) 
 
Piperine (1; 0.05 mol) was dissolved in 100 mL of 
ethanol in a 250-mL round-bottom flask. Solid 
KOH (0.05 mol) was added and the mixture 
refluxed for 24 h [9]. The reaction was monitored 
by TLC. The pH was adjusted to 5 - 6 with dilute 
HCl. The precipitated piperic acid (2) was filtered 
out, washed and dried.  
 
Synthesis of ethyl piperate (3)  
 
Piperic acid (2; 5 g) was added to 150 mL of 
ethanol along with 2.5 mL of concentrated H2SO4 
in a 250-mL round-bottom flask and the mixture 
refluxed for 7 h. Column chromatography was 
used to separate 3 from the reaction medium 
[10]. 
 
Synthesis of piperic carbohydrazide (4) 
 
Ethyl piperate (3; 0.05 mol) was added to 80 mL 
ethanol containing hydrated hydrazine (3.0 mL) 
in a 250-mL round-bottom flask and the mixture 
refluxed for 4 h [11]. The precipitate was 
obtained after evaporating the excess solvent. 
The precipitated piperic carbohydrazide (4) was 






Piperic carbohydrazide (4; 0.04 mol) was mixed 
in 150 mL of ethanol with solid KOH (0.04 mol) in 
a 250-mL round-bottom flask and the mixture 
refluxed. Carbon disulfide (0.08 mol) was added 
dropwise and the mixture refluxed for 6 h. 
Excess distilled water (100 mL) was added and 
the pH was adjusted to 5 - 6 with dilute HCl [12]. 
The title compound was collected by filtration and 
dried.  
 
Synthesis of 2-bromo-N-(alkyl/aralkyl/aryl) 
propanamides (8a-o) 
 
Alkyl/aralkyl/aryl amines (6a-o; 0.005 mol) were 
dispersed in 10% Na2CO3 in an iodine flask (250 
mL). 2-Bromopropanoyl bromide (7; 0.005 mol) 
was gradually added to the iodine flask with 
vigorous shaking for 3 - 5 min. The title 
compounds were precipitated and filtered out. 
The filtered out precipitates were thoroughly 
washed with cold distilled water and dried [10]. 
 





Compound 5 (0.001 mol) was mixed with N,N-
dimethylformamide (8 mL) with shaking in a 50-
mL round-bottom flask. The mixture was further 
stirred for 45 min with lithium hydride (0.001 mol) 
at room temperature. The synthesized 
electrophiles, 2-bromo-N-(alkyl/aralkyl/aryl) 
propanamides (8a-o), were added and the 
mixture again stirred for 4 - 5 h. Excess cold 
distilled water was poured into the mixture, which 
was then allowed to stand for 1 h. The S-
substituted derivatives of 5 were obtained as 




Tests for antimicrobial activity were performed 
using the disc diffusion method of Berghe and 
Vlietnick [14].  
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Figure 1: Protocol for the synthesis of N-substituted-2-({5-[(1E,3E)-4-(1,3-benzodioxol-5-yl)-1,3-
butadienyl]-1,3,4-oxadiazol-2-yl}sulfanyl)propanamides (9a-o) 
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Antibacterial activity was assayed against 
Bacillus subtilis (JS 2004) and Escherichia coli 
(ATCC 25922), with the reference drug being 
rifampicin, and antifungal activity against 
Aspergillus niger (locally isolated), with the 
reference drug being fluconazole. These 
microbial strains were collected through the 
Department of Clinical Medicine and Surgery, 
University of Agriculture, Faisalabad, Pakistan. 
 
Hemolytic activity assay 
 
Hemolytic activity was performed according to 
Powell et al [15]. A blood sample was collected 
from a cow, and RBCs (red blood cells) were 
isolated. Triton X-100 and phosphate buffer 
saline (PBS) were employed as references. 
 
Thrombolytic activity assay 
 
Thrombolytic activity was assayed according to 
Mannan et al [16] using a bovine blood sample. 
PBS and streptokinase were employed as 
references. Activity was determined by the 
following equation, where X represents the clot 
weight before lysis, and Y represents the clot 
weight after lysis. 
 
Inhibition (%) = [(X-Y)/X × 100  
        
Statistical analysis  
 
The antimicrobial data are presented as mean ± 
standard deviation (SD) and were analyzed by 
Students t-test using Microsoft Excel 2010. P < 




Figure 1 presents the synthesis of propanamide 
derivatives 9a-o. The varying alkyl/aralkyl/aryl 
groups are listed in Table 1. 
 





Yellow needle-like crystals; Yield: 4 %; M.P. 127-
129 oC; M.F.: C17H19NO3; M.W.: 285; IR (KBr, 
cm-1) vmax: 2950, 1650, 1620, 1600, 1250, 1140, 
1005; 1H-NMR (300 MHz, CDCl3, δ/ppm): 7.42-
7.34 (m, 1H, H-10), 6.98 (d, J = 1.5 Hz, 1H, H-2), 
6.89 (dd, J = 1.5, 7.8 Hz, 1H, H-6), 6.78-6.64 (m, 
3H, H-5,8,9), 6.45 (d, J =15.3 Hz, 1H, H-11), 
5.98 (s, 2H, H-7), 3.59-3.56 (m, 4H, H-2',6'), 
1.68-1.61 (m, 6H, H-3',4',5'); EIMS (m/z): 285 
(M+, 60%), 202 (28%), 201 (100%), 174 (23%), 
173 (44%), 115 (93%). 
 
Piperic acid (2) 
 
Light yellow crystals; Yield: 74 %; M.P. 217-218 
°C; M.F.: C12H10O4; M.W.: 218; IR (KBr, cm-1) 
vmax: 3217, 1672, 1599, 1257,1148, 1036; 1H-
NMR (400 MHz, CDCl3, δ/ppm): 7.44-7.35 (m, 
1H, H-10), 6.97 (d, J = 1.5 Hz, 1H, H-2), 6.89 
(dd, J = 1.5, 7.8 Hz, 1H, H-6), 6.77-6.63 (m, 3H, 
H-5,8,9), 5.96 (s, 2H, H-7), 5.92 (d, J =15.3 Hz, 
1H, H-11); EIMS (m/z): 218 (M+, 57%), 202 
(27%), 201 (100%), 174 (23%), 173 (44%), 115 
(93%). 
 
Ethyl piperate (3)  
 
Light yellow crystals; Yield: 64 %; M.P. 132-134 
°C; M.F.: C14H14O4; M.W.: 246; IR (KBr, cm-1) 
vmax: 2953, 2923, 1704, 1608, 1234,1134, 997; 
1H-NMR (400 MHz, CDCl3, δ/ppm): 7.43-7.34 (m, 
1H, H-10), 6.97 (d, J = 1.5 Hz, 1H, H-2),.6.89 
(dd, J = 1.5, 7.8 Hz, 1H, H-6), 6.78-6.63 (m, 3H, 
H-5,8,9), 5.96 (s, 2H, H-7), 5.92 (d, J = 15.3 
Hz,1H, H-11), 4.20 (q, J = 7.2 Hz, 2H, 
OCH2CH3), 1.29 (t, J = 7.2 Hz, 3H, OCH2CH3); 
EIMS (m/z): 246 (M+, 60%), 202 (29%), 201 
(100%), 174 (22%), 173 (43%), 115 (92%). 
 
Piperic carbohydrazide (4) 
 
Yellowish orange crystals; Yield: 72 %; M.P. 149-
150 °C; M.F.: C12H12N2O3; M.W.: 232; IR (KBr, 
cm-1) vmax: 3317, 2918, 2849, 1658, 1488, 1248, 
1038, 991; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.12-7.05 (m, 1H, H-10), 6.97 (d, J = 1.5 Hz, 1H, 
H-2), 6.90 (dd, J = 1.5, 7.8 Hz, 1H, H-6), 6.78-
6.69 (m, 3H, H-5,8,9), 5.98 (s, 2H, H-7), 5.94 (d, 
J = 15.6 Hz,1H, H-11); EIMS (m/z): 232 (M+, 
23%), 167 (42%), 149 (100%), 57 (38%), 71 





Bright yellowish orange crystals; Yield: 75 %; 
M.P. 215-217 °C; M.F.: C13H10N2O3S; M.W.: 274; 
IR (KBr, cm-1) vmax: 2935, 2849, 2536, 1655, 
1537, 1250,1144, 1034; 1H-NMR (300 MHz, 
CDCl3, δ/ppm): 7.30-7.24 (m, 1H, H-10), 6.97 (s, 
1H, H-2), 6.90 (d, J = 8.0 Hz, 1H, H-6), 6.78-6.73 
(m, 3H, H-5,8,9), 5.97-5.96 (m, 3H, H-7,11); 
EIMS (m/z): 215 (5.8%), 201 (20%), 199 (20%), 






Light yellow crystals; Yield: 70 %; M.P. 111-112 
°C; M.F.: C22H25N3O4S; M.W.: 427; IR (KBr, cm-1) 
vmax: 3250, 2930, 2830, 1670, 1645, 1490, 1250, 
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1045, 980; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.29-7.25 (m, 1H, H-10). 7.01 (d, J = 1.2 Hz, 1H, 
H-2), 6.93 (dd, J = 8.1, 1.5 Hz, 1H, H-6), 6.84-
6.73 (m, 3H, H-5,8,9), 6.48 (d, J = 15.6 Hz, 1H, 
H-11), 6.01 (s, 2H, H-7), 3.80 (br.s, 1H, 2ꞌ), 3.32 
(s, 1H, H-1ꞌꞌ), 1.77 (d, J = 8.1 Hz, 3H, H-3ꞌ), 1.55-
1.16 (m, 10H, H-2ꞌꞌ to H-6ꞌꞌ); EIMS (m/z): 427 
(M+), 167 (40%), 149 (100%), 57 (36%), 71 






Yellowish brown crystals; Yield: 75 %; M.P. 114-
115 °C; M.F.: C23H21N3O4S; M.W.: 435; IR (KBr, 
cm-1) vmax: 3250, 2920, 2825, 1673, 1650, 1440, 
1250, 1040, 970; 1H-NMR (300 MHz, CDCl3, 
δ/ppm): 7.41-7.33 (m, 5H, H-2ꞌꞌ to H-6ꞌꞌ),7.21-
7.19 (m, 1H, H-10), 6.97 (d, J = 1.5 Hz, 1H, H-2), 
6.89 (dd, J = 8.1, 1.5 Hz, 1H, H-6), 6.82-6.60 (m, 
3H, H-5,8,9), 6.35 (d, J = 14.6 Hz, 1H, H-11), 
6.01 (s, 2H, H-7), 4.43 (s, 2H, H-7ꞌꞌ), 4.22-4.36 
(m, 1H, H-2ꞌ), 1.76 (d, J = 8.1 Hz, 3H, H-3ꞌ); 
EIMS (m/z): 435 (M+), 167 (41%), 149 (100%), 






Light yellow crystals; Yield: 73 %; M.P. 115-116 
°C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, cm-1) 
vmax: 3340, 2980, 2805, 1675, 1655, 1450, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.78-7.54 (m, 2H, H-3ꞌꞌ,5ꞌꞌ), 7.33-7.21 (m, 3H, H- 
2 ꞌꞌ , 4ꞌꞌ & H-6ꞌꞌ), 7.03-6.75 (m, 7H, H-
2,5,6,8,9,10,11), 6.00 (s, 2H, H-7), 4.10-4.04 (m, 
1H, H-2ꞌ), 3.04 (t, J = 8.1 Hz, 2H, H-8ꞌꞌ), 2.81 (t, J 
= 7.5 Hz, 2H, H-7ꞌꞌ), 1.59 (d, J = 8.1 Hz, 3H, H-
3ꞌ); EIMS (m/z): 449 (M+), 167 (40%), 149 






Light yellow crystals; Yield: 65 %; M.P. 110-111 
°C; M.F.: C22H19N3O4S; M.W.: 421; IR (KBr, cm-1) 
vmax: 3330, 2980, 2875, 1674, 1661, 1489, 1250, 
1045, 980; 1H-NMR (300 MHz, CDCl3, 
δ/ppm):7.41-7.33 (m, 5H, H-2ꞌꞌ to 6ꞌꞌ),7.21-6.98 
(m, 2H, H-2,10), 6.98 (d, J = 8.1 Hz, 1H, H-6), 
6.91-6.74 (m, 3H, H-5,8,9), 6.34 (d, J = 14.6 Hz, 
1H, H-11), 6.01 (s, 2H, H-7), 4.37-4.24 (m, 1H, 
H-2ꞌ), 1.79 (d, J = 8.1 Hz, 3H, H-3ꞌ); EIMS (m/z): 
421 (M+), 167 (42%), 149 (100%), 57 (37%), 71 






Light brown crystals; Yield: 70 %; M.P. 168-169 
°C; M.F.: C23H21N3O4S; M.W.: 435; IR (KBr, cm-1) 
vmax: 3350, 2985, 2875, 1678, 1651, 1497, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.79 (d, J = 8.2 Hz, 1H, 6ꞌꞌ),7.24 (d, J = 7.8 Hz, 
1H, H-3ꞌꞌ), 7.19 (t, J = 7.8 Hz, 1H, H-5ꞌꞌ), 7.15 (t, J 
= 7.8 Hz, 1H, H-4ꞌꞌ), 7.13-7.09 (m, 1H, H-10), 
7.08-7.02 (m, 1H, H-2), 6.92 (d, J = 8.1 Hz, 1H, 
H-6), 6.81-6.77 (m, 3H, H-5,8,9), 6.40-6.34 (m, 
1H, H-11), 6.01 (s, 2H, H-7), 4.39-4.33 (m, 1H, 
H-2ꞌ), 2.41 (s, 3H, H-7ꞌꞌ), 1.82 (d, J = 6.9 Hz, 3H, 
H-3ꞌ); EIMS (m/z): 435 (M+), 167 (40%), 149 






Dark brownish yellow crystals; Yield: 70 %; M.P. 
190-191 °C; M.F.: C23H21N3O4S; M.W.: 435; IR 
(KBr, cm-1) vmax: 3555, 2980, 2875, 1672, 1645, 
1489, 1250, 1045, 995; 1H-NMR (300 MHz, 
CDCl3, δ/ppm): 7.59 (d, J = 8.4 Hz, 1H, H-6ꞌꞌ), 
7.34 (s, 1H, H-2ꞌꞌ), 7.15 (t, J = 8.1 Hz, 1H, H-5ꞌꞌ), 
7.05 (t, J = 7.8 Hz, 1H, H-4ꞌꞌ), 7.13-7.09 (m, 1H, 
H-10), 7.08-7.02 (m, 1H, H-2), 6.92 (d, J = 8.1 
Hz, 1H, H-6), 6.81-6.77 (m, 3H, H-5,8,9), 6.40-
6.34 (m, 1H, H-11), 6.01 (s, 2H, H-7), 4.39-4.33 
(m, 1H, H-2ꞌ), 2.36 (s, 3H, CH3-7ꞌꞌ), 1.82 (d, J = 
6.9 Hz, 3H, H-3ꞌ); EIMS (m/z): 435 (M+), 167 







Bright yellow crystals; Yield: 69 %; M.P. 122-123 
°C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, cm-1) 
vmax: 3350, 2985, 2875, 1682, 1656, 1479, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.23 (dd, J = 8.2, 2.8 Hz, 1H, H-6ꞌꞌ), 7.21-7.17 
(m, 1H, H-10), 7.18 (dt, J = 8.2, 2.6 Hz, 1H, H-
5ꞌꞌ), 7.09 (dt, J = 8.2, 2.8 Hz, 1H, H-4ꞌꞌ), 7.08 (d, J 
= 1.5 Hz, 1H, H-2), 7.03 (dd, J = 8.2, 2.8 Hz, 1H, 
H-3ꞌꞌ), 6.91 (dd, J = 8.1, 1.5 Hz, 1H, H-6), 6.88-
6.62 (m, 3H, H-5,8,9), 6.37 (d, J = 14.6 Hz, 1H, 
H-11), 5.98 (s, 2H, H-7), 4.35-4.25 (m, 1H, H-2ꞌ), 
2.75 (q, J = 7.9 Hz, 2H, H-7ꞌꞌ), 2.13 (t, J = 7.8 Hz, 
3H, H-8ꞌꞌ), 1.81 (d, J = 8.1 Hz, 3H, H-3ꞌ); EIMS 
(m/z): 449 (M+), 167 (40%), 149 (100%), 57 
(35%), 71 (22%), 43 (20%). 
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Light yellowish crystals; Yield: 69 %; M.P. 167-
168 °C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, 
cm-1) vmax: 3250, 2935, 2850, 1675, 1650, 1478, 
1250, 1030, 980; 1H-NMR (300 MHz, CDCl3, 
δ/ppm): 7.56-7.30 (m, 4H, H-2ꞌꞌ,3ꞌꞌ,5ꞌꞌ,6ꞌꞌ), 7.21-
7.18 (m, 1H, H-10), 6.99 (d, J = 1.5 Hz, 1H, H-2), 
6.89 (dd, J = 8.1, 1.5 Hz, 1H, H-6), 6.82-6.60 (m, 
3H, H-5,8,9), 6.35 (d, J = 14.6 Hz, 1H, H-11), 
6.00 (s, 2H, H-7), 4.36-4.22 (m, 1H, H-2ꞌ), 2.75 
(q, J = 7.9 Hz, 2H, H-7ꞌꞌ), 2.11 (t, J = 7.8 Hz, 3H, 
H-8ꞌꞌ), 1.79 (d, J = 8.1 Hz, 3H, H-3ꞌ); EIMS (m/z): 
449 (M+), 167 (40%), 149 (100%), 57 (35%), 71 






Dark brownish crystals; Yield: 66 %; M.P. 151-
152 °C; M.F.: C24H23N3O5S; M.W.: 465; IR (KBr, 
cm-1) vmax: 3250, 2935, 2850, 1671, 1655, 1480, 
1250, 1040, 980; 1H-NMR (300 MHz, CDCl3, 
δ/ppm): 7.60-7.35 (m, 4H, H-2ꞌꞌ,3ꞌꞌ,5ꞌꞌ,6ꞌꞌ), 7.22-
7.18 (m, 1H, H-10), 6.98 (d, J = 1.5 Hz, 1H, H-2), 
6.90 (dd, J = 8.1, 1.5 Hz, 1H, H-6), 6.85-6.61 (m, 
3H, H-5,8,9), 6.37 (d, J = 14.4 Hz, 1H, H-11), 
5.99 (s, 2H, H-7), 4.33-4.24 (m, 1H, H-2ꞌ), 3.99 
(q, J = 7.4 Hz, 2H, H-7ꞌꞌ), 1.78 (d, J = 8.1 Hz, 3H, 
H-3ꞌ), 1.32 (t, J = 7.4 Hz, 3H, H-8ꞌꞌ); EIMS (m/z): 
465 (M+), 167 (40%), 149 (100%), 57 (35%), 71 






Yellowish brown crystals; Yield: 75 %; M.P. 198-
199 °C; M.F.: C23H21N3O5S; M.W.: 451; IR (KBr, 
cm-1) vmax: 3350, 2985, 2875, 1684, 1667, 1480, 
1250, 1045, 990; 1H-NMR (300 MHz, CDCl3, 
δ/ppm): 8.20 (d, J = 7.6 Hz, 1H, H-6ꞌꞌ), 7.24-7.20 
(m, 1H, H-10), 7.07 (t, J = 7.2 Hz, 1H, H-5ꞌꞌ),7.04 
(t, J = 7.6 Hz, 1H, H-4ꞌꞌ), 6.96 (d, J = 8.0 Hz, 1H, 
H-3ꞌꞌ), 6.92 (d, J = 1.5 Hz, 1H, H-2), 6.88 (dd, J = 
8.1, 1.5 Hz, 1H, H-6), 6.87-6.63 (m, 3H, H-5,8,9), 
6.36 (d, J = 14.6 Hz, 1H, H-11), 5.99 (s, 2H, H-
7), 4.36-4.29 (m, 1H, H-2ꞌ), 3.80 (s, 3H, H-7ꞌꞌ), 
1.82 (d, J = 8.1 Hz, 3H, H-3ꞌ); EIMS (m/z): 451 
(M+),167 (40%), 149 (100%), 57 (35%), 71 






Light yellow crystals; Yield: 69 %; M.P. 158-159 
°C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, cm-1) 
vmax: 3497, 2985, 2870, 1678, 1670, 1485, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.68 (d, J = 8.2 Hz, 1H, H-6ꞌꞌ),7.14-7.09 (m, 1H, 
H-10), 7.05 (d, J = 8.2 Hz, 1H, H-5ꞌꞌ),6.95 (s, 1H, 
H-3ꞌꞌ),6.92 (d, J = 1.4 Hz, 1H, H-2), 6.91 (d, J = 
8.1, 1H, H-6), 6.77-6.63 (m, 3H, H-5,8,9), 6.36 
(d, J = 14.6 Hz, 1H, H-11), 6.01 (s, 2H, H-7), 
4.36-4.30 (m, 1H, H-2ꞌ), 2.21 (s, 6H, H-7ꞌꞌ, 8ꞌꞌ), 
1.81 (d, J = 6.9 Hz, 3H, H-3ꞌ); EIMS (m/z): 449 
(M+), 167 (40%), 149 (100%), 57 (35%), 71 






Light yellow solid; Yield: 71 %; M.P. 141-142 °C; 
M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, cm-1) 
vmax: 3250, 2930, 2850, 1673, 1664, 1480, 1250, 
1040, 980; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.19 (s, 1H, H-6ꞌꞌ), 7.08-7.15 (m, 1H, H-10), 7.04 
(d, J = 8.0 Hz, 1H, H-3ꞌꞌ), 6.94 (d, J = 8.0 Hz, 1H, 
H -4ꞌꞌ), 6.92 (s, 1H, H-2), 6.91 (d, J = 8.1, 1H, H-
6), 6.78-6.83 (m, 2H, H-5,8), 6.66-6.58 (m, 1H, 
H-9), 6.35-6.31 (m, 1H, H-11), 6.00 (s, 2H, H-7), 
4.36-4.31 (m, 1H, H-2ꞌ), 2.41 (s, 3H, H-7ꞌꞌ), 2.24 
(s, 3H, H-8ꞌꞌ), 1.81 (d, J = 6.9 Hz, 3H, H-3ꞌ); EIMS 
(m/z): 449 (M+), 167 (41%), 149 (100%), 57 






Yellowish brown crystals; Yield: 69 %; M.P. 167-
168 °C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, 
cm-1) vmax: 3290, 2920, 2825, 1677, 1657, 1477, 
1250, 1040, 980; 1H-NMR (300 MHz, CDCl3, 
δ/ppm): 7.15-7.11 (m, 1H, H-10), 7.10-7.07 (m, 
3H, H-3ꞌꞌ to 5ꞌꞌ), 6.94 (s, 1H, H-2), 6.92 (d, J = 8.1 
Hz, 1H, H-6), 6.81-6.67 (m, 3H, H-5,8,9), 6.34-
6.29 (m, 1H, H-11), 6.02 (s, 2H, H-7), 4.31-4.29 
(m, 1H, H-2ꞌ), 2.46 (s, 6H, H-7ꞌꞌ,8ꞌꞌ), 1.80 (d, J = 
6.9 Hz, 3H, H-3ꞌ); EIMS (m/z):449 (M+), 167 







Light brown crystals; Yield: 79 %; M.P. 143-144 
°C; M.F.: C24H23N3O4S; M.W.: 449; IR (KBr, cm-1) 
vmax: 3350, 2985, 2875, 1678, 1659, 1476, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.13-7.09 (m, 1H, H-10), 6.97-6.93 (m, 2H, H-
2,4ꞌꞌ), 7.52-7.42 (m, 2H, H-2ꞌꞌ,6ꞌꞌ), 6.90 (d, J = 8.1 
Hz, 1H, H-6), 6.81-6.77 (m, 2H, H-5,8), 6.66-6.61 
(m, 1H, H-9), 6.40-6.34 (m, 1H, H-11), 6.00 (s, 
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2H, H-7), 4.35-4.33 (m, 1H, H-2ꞌ), 2.40 (s, 6H, H-
7ꞌꞌ,8ꞌꞌ), 1.80 (d, J = 6.9 Hz, 3H, H-3ꞌ); EIMS (m/z): 







Light yellow crystals; Yield: 69 %; M.P. 120-121 
°C; M.F.: C25H25N3O4S; M.W.: 463; IR (KBr, cm-1) 
vmax: 3350, 2985, 2875, 1681, 1669, 1498, 1250, 
1045, 990; 1H-NMR (300 MHz, CDCl3, δ/ppm): 
7.17-7.00 (m, 3H, H-3ꞌꞌ to 5ꞌꞌ), 7.15-7.08 (m, 1H, 
H-10), 6.97 (s 1H, H-2), 6.92 (d, J = 8.1 Hz, 1H, 
H-6), 6.81-6.78 (m, 2H, H-5,8), 6.67-6.65 (m, 1H, 
H-9), 6.37-6.34 (m, 1H, H-11), 6.01 (s, 2H, H-7), 
4.33-4.31 (m, 1H, H-2ꞌ), 2.49 (q, J = 7.6 Hz, 2H, 
H-7ꞌꞌ), 1.99 (s, 3H, H-9ꞌꞌ), 1.81 (d, J = 6.9 Hz, 3H, 
H-3ꞌ), 1.05 (t, J = 7.6 Hz, 3H, H-8ꞌꞌ); EIMS (m/z): 
463 (30%) [M+], 167 (40%), 149 (100%), 57 
(35%), 71 (22%), 43 (20%). 
 
Antibacterial activity  
 
Table 2 and Table 3 show the results for 
antimicrobial, hemolytic and thrombolytic 
activities. The target compounds were more 
active antimicrobial agents than the alkaloid 
piperine. Compounds 9a and 9d bearing 
cyclohexyl and phenyl groups, respectively, 




Compound, 9n, has been selected for single 
compound discussion. The EIMS spectrum and 
proton integration in 1H-NMR spectrum helped to 
determine its molecular formula and molecular 
mass. IR spectra showed prominent absorption 
bands (cm-1) at 3350, 2985, 2875, 1659, 1678, 
1600-1450, 1250 and 1045 for N-H, C-H 
(symmetric and asymmetric), C=N and NC=O, 
respectively, which are indicative of aromatic 
systems and methylenedioxy (symmetric and 
asymmetric) functionalities. 
 
In the aliphatic region of 1H-NMR, two signals as 
doublet and multiplet at δ 4.35-4.33 (m, 1H, H-2ꞌ) 
and 1.80 (d, J = 6.9 Hz, 3H, H-3ꞌ) supported the 
presence of a propanamoyl group. A singlet at δ 
2.40 (s, 6H, H-7ꞌꞌ,8ꞌꞌ) was ascribed to two methyl 
groups linked to benzene ring. The two 
methylenic protons were shown by a singlet at δ 
6.00 (s, 2H, H-7). The remaining part of the 
molecule was justified by the signals in the 
aromatic and olefinic region at δ 7.13-7.09 (m, 
1H, H-10), 6.97-6.93 (m, 2H, H-2,4ꞌꞌ), 7.52-7.42 
(m, 2H, H-2ꞌꞌ,6ꞌꞌ), 6.90 (d, J = 8.1 Hz, 1H, H-6), 
6.81-6.77 (m, 2H, H-5,8), 6.66-6.61 (m, 1H, H-9) 
and 6.40-6.34 (m, 1H, H-11). 
 
Table 2: Zone of inhibition (mm) for antimicrobial activity of 1-5 and 9a-o 
 
 Zone of inhibition (mm) 
Compound 
Antibacterial activity Antifungal activity 
Bacillus subtilis Escherichia coli Aspergilus niger 
1 - - - 
2 - - - 
3 - - - 
4 - - - 
5 7 9 7 
9a 14 15 18 
9b 12 9 8 
9c 12 11 14 
9d 16 16 17 
9e 7 9 7 
9f 10 8 9 
9g 15 17 13 
9h - - - 
9i 13 10 12 
9j - - - 
9k 12 12 10 
9l - - - 
9m 14 15 12 
9n - - - 
9o 10 11 10 
Rifampicin 21 23 - 
Fluconazole - - 19 
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Table 3: Hemolytic and thrombolytic activities of 1-5 and 9a-o 
 
Compound Hemolytic activity (%) 
Thrombolytic activity 
(%) 
1 19.27 9.67 
2 10.13 13.16 
3 13.58 3.45 
4 2.55 12.43 
5 11.62 1.32 
9a 42.99 4.19 
9b 14.06 4.85 
9c 15.85 25.56 
9d 41.93 31.49 
9e 49.61 39.54 
9f 45.55 35.34 
9g 42.99 22.54 
9h 20.71 25.61 
9i 39.38 33.78 
9j 74.73 7.53 
9k 15.50 10.30 
9l 21.71 14.63 
9m 1.00 1.43 
9n 7.92 17.32 
9o 41.81 21.65 
Triton X-100 98.74 - 
PBS 0.5 0.5 
Streptokinase - 85.64 
 
The absence of a molecular ion peak indicated 
instability of the compound in the mass 
spectrometer. The base peak appeared at m/z 
149 due to a 1,3-benzodioxol-5-ylethane cation. 
The other prominent peaks at 167 and 57 were 
for 2-(5-ethyl-1,3,4-oxadiazolidin-2-ylthio)ethe-
none and 3-methyl-1,2-oxazirene, respectively. 







The results proved that the inclusion of the 1,3,4-
oxadiazole and propanamide functionality 
enhanced the antimicrobial behavior of the 
compounds. The initial compounds 1-4 showed 
no activity at all; however, 5 with a 1,3,4-
oxadiazole ring exhibited some zone inhibition 
and target molecules were more bioactive. 
Compounds 9a, 9d, 9g and 9m exhibited better 
activity against B. substilis (Gram positive) with 
zone inhibition values of 14, 16, 15 and 14 mm, 
respectively, compared to the reference drug 
with 21 mm. The same four compounds showed 
better results against E. coli (Gram negative) with 
zone inhibition values of 15, 16, 17 and 15 mm, 
respectively, compared to the reference drug 
with 23 mm. Against A. niger, compounds 9a, 9c 
and 9d had the highest activity with zone 
inhibition values of 18, 14 and 17, respectively, 
compared to the reference drug with 19 mm.  
 
Hemolytic and thrombolytic activities 
 
Among the list of compounds, 4, 9m and 9n 
showed the least toxicity. Compounds 9e and 9f 
showed the highest toxicity. Moderate toxicity 
was exhibited by compounds 9b, 9c, 9h, 9k and 
9l. Those compounds that showed low or 
moderate toxicity could be used in a drug 
discovery program. With regard to thrombolytic 
activity, piperine showed a low clot lysis 
percentage, which increased when the piperine 
nucleus was modified, creating the different 
compounds 9a-o. Compounds 9d, 9e, 9f and 9i 
were found to be the most active ones. 
   
CONCLUSION  
 
Compounds 9a, 9d, 9g and 9m possess good 
antibacterial and antifungal activities. Some of 
the synthesized compounds also exhibit some 
level of hemolytic and thrombolytic activities, and 
have shown enough potentials to be considered 
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